UPDATE: Barclays Downgrades United Therapeutics Corp. (UTHR) to Underweight

November 29, 2016 6:40 AM EST
Get Alerts UTHR Hot Sheet
Price: $129.37 --0%

Rating Summary:
    8 Buy, 12 Hold, 3 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 15
Trade UTHR Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.
(Updated - November 29, 2016 8:19 AM EST)

Barclays downgraded United Therapeutics Corp. (NASDAQ: UTHR) from Equalweight to Underweight with a price target of $100.00 (from $115.00). Analyst Geoff Meacham said Orenitram uptake will likely be hindered due to Uptravi.

For an analyst ratings summary and ratings history on United Therapeutics Corp. click here. For more ratings news on United Therapeutics Corp. click here.

Shares of United Therapeutics Corp. closed at $132.74 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Analyst Comments, Analyst PT Change, Downgrades

Related Entities

Barclays

Add Your Comment